Share your videos with the world

Sign Up | Log In | Help  

   
 
Related Tags: nma  national  meningitis  association  health  vaccines  educate  meningitis  awareness  multivu  8385951  sanofi  vaccines  health  treatment  fluzone  flu  fda  medical  healthcare  multivu  8081151  medical  vaccines  seqirus  influenza  technology  fluad  cure  afluria  fluvirin  multivu  7902351  flu  vaccine  health  healthcare  fluzone  fda  pharmacies  sanofi  medical  multivu  7842051  children  pneumonia  health  disease  united  nations  vaccine  awareness  donations  immunization  programs  multivu  7616651  issels  integrative  immunotherapy  lung  cancer  alternative  treatment  remission  vaccines  cell  therapy  multivu  65511  adenocarcinoma  appendix  cancer  patients  health  immunotherapy  dendritic  cell  vaccine  multivu  64654  influenza  flu  vaccination  medimmune  flumist  quadrivalent  vaccines  tai  mowry  family  health  multivu  63079  walgreens  pharmacy  flu  influenza  vaccine  amanda  peet  un  foundation  children  vaccination  immunization  health  multivu  merck  teenagers  children  vaccines  webmd  healthywomen  childhood  vaccination  parents  immunization  health  multivu  62743  sanofi  pasteur  clostridium  difficile  infection  vaccine  bacteria  cdiffense  health  study  multivu  62652  global  vaccine  summit  child  vaccination  health  disease  immunization  bill  gates  healthcare  multivu  61396 
Search // vaccines
Results 1-12 of 16 for ' vaccines ' (0 seconds)
The National Meningitis Association (NMA) today announced the launch of a new educational initiative in collaboration with Sanofi Pasteur, the vaccines division of Sanofi, about the importance of the Centers for Disease Control and Prevention’s (CDC’s) recommended second dose of the meningococcal meningitis vaccine (MenACWY) for adolescents at age 16. The 16 Vaccine (The16Vaccine.org) aims to educate parents about the importance of this critical second dose of MenACWY, which helps protect teens against meningococcal meningitis during the period when they are at increased risk. To view the multimedia release go to: https://www.multivu.com/players/English/8385951-national-meningitis-association-the-16-vaccine/
Categories // Miscellaneous 
Added: 803 days ago by MultiVuVideos
Runtime: 1m44s | Views: 124 | Comments: 0
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of the Fluzone® (Influenza Vaccine) portfolio for the 2017-2018 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA). Sanofi Pasteur has begun distributing initial shipments, representing the first of nearly 70 million total doses of seasonal influenza vaccine manufactured by the company for this upcoming influenza season. Widespread shipment of Fluzone Quadrivalent, Fluzone High-Dose and Fluzone Intradermal Quadrivalent vaccine to health care provider offices, pharmacies and other immunizers will begin in early August to support fall immunization campaigns. “As we enter the Swiftwater site’s 120th year, it reminds us of our innovation and growth as we came to understand the science of influenza and its impact on human health,” said David P. Greenberg, M.D., Associate Vice President and Regional Medical Head North America, Sanofi Pasteur. “Influenza can be especially severe for the most vulnerable populations, including the elderly, young children and those with compromised immune systems; however, it can also have a serious health impact on otherwise healthy individuals. Sanofi Pasteur is and always has been deeply committed to improving public health by continuously striving to develop new vaccines and on improving existing ones.” To view the multimedia release go to: https://www.multivu.com/players/English/8081151-sanofi-pasteur-influenza-vaccine-first-shipment-2017/
Categories // Miscellaneous 
Added: 1231 days ago by MultiVuVideos
Runtime: 1m27s | Views: 114 | Comments: 1
Not yet rated
 

 

 

Seqirus is now shipping its complete portfolio of seasonal influenza vaccines to customers in the US market for the 2016-2017 season. Seqirus is the only influenza vaccine manufacturer to produce influenza vaccines using both egg-based and cell culture technologies, and the only provider in the US that offers both quadrivalent and trivalent influenza vaccines, as well as the only adjuvanted seasonal influenza vaccine. Seqirus is now shipping to the US all influenza vaccines in its portfolio, including Fluad™ (Influenza Vaccine, Adjuvanted), Flucelvax Quadrivalent™ (Influenza Vaccine), Afluria® (Influenza Vaccine), and Fluvirin® (Influenza Virus Vaccine) in advance of the peak of influenza season. “Seqirus is proud to be a major contributor to the prevention and control of influenza by offering healthcare providers and pharmacists with a range of clinically proven, innovative vaccination options that help protect people against the debilitating effects of the disease,” said Brent MacGregor, Senior Vice President, Commercial Operations. “We are committed to being an early and reliable supplier of our influenza vaccines to help ensure that appropriate patients have plenty of time to get their annual immunization.” To view the multimedia release go to: http://www.multivu.com/players/English/7902351-seqirus-franchise-shipment/
Categories // Miscellaneous 
Added: 1565 days ago by MultiVuVideos
Runtime: 5m12s | Views: 243 | Comments: 0
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today that its first doses of Fluzone® (Influenza Vaccine) for the 2016-2017 influenza (“flu”) season have been released by the U.S. Food and Drug Administration (FDA) for shipment. This represents the first of more than 65 million total doses of seasonal influenza vaccine manufactured by Sanofi Pasteur that will be delivered to U.S. health care providers and pharmacies beginning in July and continuing throughout the remainder of the year. Sanofi Pasteur plans to increase its supply to respond to the shifting pediatric public health needs. Seasonal influenza activity typically occurs between October and May and peaks between December and February. However, influenza activity peaked noticeably late last season occurring in early March 2016.1 Influenza seasons are always unpredictable as new influenza strains emerge and strain activity fluctuates throughout the year, making timely vaccination even more important to help protect against the virus, especially for seniors, young children and infants six months of age and older. To view the multimedia release go to: http://www.multivu.com/players/English/7842051-sanofi-pasteur-influenza-vaccine/
Categories // Miscellaneous 
Added: 1588 days ago by MultiVuVideos
Runtime: 4m50s | Views: 280 | Comments: 0
Not yet rated
 

 

 

The United Nations Foundation’s Shot@Life campaign marks World Pneumonia Day, November 12, by asking Americans to raise awareness, funds and advocate to members of Congress to support global immunization programs. Pneumonia kills nearly a million children under the age of five each year and almost half of those deaths are vaccine-preventable. “Around the world one in five children lack access to the vaccines they need,” said Devi Thomas, Director, UN Foundation’s Shot@Life campaign. “By raising awareness, funding and asking members of Congress to support global immunization programs we can ensure that every child, no matter where they live, is given a shot at a healthy life.” To view the multimedia release go to: http://www.multivu.com/players/English/7616651-shotatlife-united-nations-vaccines/
Categories // Miscellaneous 
Added: 1844 days ago by MultiVuVideos
Runtime: 0m39s | Views: 260 | Comments: 0
Not yet rated
 

 

 

Lung cancer is the most common cause of cancer-related death worldwide, with the highly malignant small cell lung cancer having the worst prognosis. In recent years the surge of immunotherapy has given cancer sufferers new hope. To view the Multimedia News Release, go to http://www.multivu.com/mnr/65511-issels-integrative-immunotherapy-non-toxic-treatment-lung-cancer
Added: 2484 days ago by MultiVuVideo
Runtime: 4m34s | Views: 1202 | Comments: 1
Not yet rated
 

 

 

In recent years there has been a shift in the understanding of cancer. Immunotherapy with vaccines has been emerging as the most promising direction towards a decisive improvement of treatment outcomes. The Dendritic Cell Vaccine has received FDA approval for prostate cancer and trials are now under way for a variety of other cancers. These vaccines are usually administered on their own. To view Multimedia News Release, go to http://www.multivu.com/mnr/64654-issels-integrative-immunotherapy-for-standard-therapy-resistant-cancers
Categories // People and Blog 
Added: 2551 days ago by MultiVuVideos
Runtime: 4m46s | Views: 490 | Comments: 1
Not yet rated
 

 

 

Today, MedImmune Specialty Care division of AstraZeneca (MedImmune Specialty Care) announced it has joined with actress Tia Mowry to raise awareness about the importance of an annual flu vaccination. To kick-off the campaign, MedImmune Specialty Care and Mowry unveiled an online video, “I Insist!” (www.YouTube.com/InsistOnTheMist), which uses comedy to educate busy families about the importance of living a healthy lifestyle and making flu vaccination a priority. For Mowry, this includes vaccination with FluMistQuadrivalent, the first and only FDA-approved needle-free flu vaccine for eligible persons 2-49 years old. FluMist Quadrivalent is administered as a gentle mist sprayed into the nose, where the influenza virus usually enters the body. To view Multimedia News Release, go to http://www.multivu.com/mnr/63079-medimmune-specialty-care-tia-mowry-flumist-quadrivalent-encourage-flu-shot
Categories // Business 
Added: 2624 days ago by MultiVuVideos
Runtime: 3m24s | Views: 1460 | Comments: 1
Not yet rated
 

 

 

Building upon its efforts to provide greater access to vaccines and other health care services for populations in need, Walgreens (NYSE: WAG) (Nasdaq: WAG) is partnering with the United Nations Foundation this flu season, to help provide up to 3 million life-saving vaccines to children in developing countries through a donation to the Foundation’s Shot@Life campaign. To view Multimedia News Release, go to http://www.multivu.com/players/English/62923-walgreens-flu-season2013
Categories // People and Blog  Business 
Added: 2643 days ago by MultiVuVideos
Runtime: 0m30s | Views: 1503 | Comments: 1
Not yet rated
 

 

 

Many parents had their children vaccinated when they were younger, but some vaccines are also recommended for older children. Beyond focusing on school supplies, extracurricular activities, and fall schedules, the back-to-school time is a good opportunity for parents to talk with their health care professional about vaccines that may be recommended for their preteen or teen. To view the Multimedia News Release, go to http://www.multivu.com/mnr/62743-merck-webmd-healthywomen-back-to-school-means-back-to-vaccines
Categories // Family  People and Blog 
Added: 2666 days ago by MultiVuVideos
Runtime: 1m58s | Views: 1488 | Comments: 2
Not yet rated
 

 

 

Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the initiation of its Phase III clinical program called Cdiffense to evaluate the safety, immunogenicity and efficacy of an investigational vaccine for the prevention of primary symptomatic Clostridium difficile infection (CDI). Clostridium difficile (C. diff) is a potentially life-threatening, spore-forming bacterium that causes intestinal disease. The risk of C. diff increases with age, antibiotic treatment and time spent in hospitals or nursing homes, where multiple cases can lead to outbreaks. The investigational vaccine is designed to help protect at-risk individuals from C. diff, which is emerging as a leading cause of life-threatening, healthcare-associated infections (HAIs) worldwide. To view the Multimedia News Release, go to http://www.multivu.com/mnr/62652-sanofi-pasteur-initiates-phase-iii-study-of-investigational-vaccine
Categories // Business  Science and Technology 
Added: 2673 days ago by MultiVuVideos
Runtime: 1m59s | Views: 1126 | Comments: 1
Not yet rated
 

 

 

More than 300 global leaders, health and development experts, vaccinators, celebrities, philanthropists, and business leaders will gather tomorrow in Abu Dhabi in the first Global Vaccine Summit to endorse the critical role that vaccines and immunization play in giving children a healthy start to life. Despite tremendous progress, one child still dies every 20 seconds from preventable diseases like pneumonia, rotavirus, measles, and meningitis. To view Multimedia News Release, go to http://www.multivu.com/mnr/61396-bill-and-melinda-gates-foundation-first-global-vaccine-summit
Categories // People and Blog 
Added: 2777 days ago by MultiVuVideos
Runtime: 1m44s | Views: 1045 | Comments: 0
Not yet rated
 

 

 

Page 1 of 2  |  Go to page    Next» LAST»»



About Us   |   Help  |   Advertise on ClipMoon   |   Terms of Use   |   Privacy Policy   |   Copyright   |   Contact   |   Link us   |   RSS 
Copyright © 2007-2020 ClipMoon.com. All rights reserved.